Vetoquinol (VETO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.026x

Based on the latest financial reports, Vetoquinol (VETO) has a cash flow conversion efficiency ratio of 0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.72 Million ≈ $17.21 Million USD) by net assets (€567.53 Million ≈ $663.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VETO equity financing ratio to measure how much of total assets are equity-financed.

Vetoquinol - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Vetoquinol's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VETO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Vetoquinol Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vetoquinol ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen WOTE Advanced Materials Co Ltd
SHE:002886
0.017x
Harbin Gloria Pharmaceuticals
SHE:002437
0.076x
Shenzhen Strongteam Decoration Engineering Co Ltd
SHE:002989
0.151x
Lintes Technology Co Ltd
TW:6715
-0.004x
AMAG Austria Metall AG
VI:AMAG
0.035x
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
0.071x
Henan Yicheng New Energy Co Ltd
SHE:300080
-0.019x
Pearl Global Industries Limited
NSE:PGIL
0.190x

Annual Cash Flow Conversion Efficiency for Vetoquinol (2004–2024)

The table below shows the annual cash flow conversion efficiency of Vetoquinol from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Vetoquinol.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €575.93 Million
≈ $673.33 Million
€85.83 Million
≈ $100.34 Million
0.149x -12.13%
2023-12-31 €527.11 Million
≈ $616.25 Million
€89.39 Million
≈ $104.51 Million
0.170x +30.77%
2022-12-31 €484.66 Million
≈ $566.62 Million
€62.85 Million
≈ $73.48 Million
0.130x -36.20%
2021-12-31 €441.35 Million
≈ $515.99 Million
€89.72 Million
≈ $104.89 Million
0.203x -18.05%
2020-12-31 €371.83 Million
≈ $434.71 Million
€92.23 Million
≈ $107.83 Million
0.248x +84.03%
2019-12-31 €385.98 Million
≈ $451.25 Million
€52.02 Million
≈ $60.82 Million
0.135x +29.18%
2018-12-31 €363.08 Million
≈ $424.48 Million
€37.88 Million
≈ $44.29 Million
0.104x -15.03%
2017-12-31 €335.73 Million
≈ $392.50 Million
€41.23 Million
≈ $48.20 Million
0.123x -10.05%
2016-12-31 €316.48 Million
≈ $369.99 Million
€43.20 Million
≈ $50.51 Million
0.137x +1.61%
2015-12-31 €289.49 Million
≈ $338.45 Million
€38.90 Million
≈ $45.47 Million
0.134x -12.68%
2014-12-31 €268.40 Million
≈ $313.78 Million
€41.30 Million
≈ $48.28 Million
0.154x +29.18%
2013-12-31 €235.96 Million
≈ $275.86 Million
€28.11 Million
≈ $32.86 Million
0.119x -20.61%
2012-12-31 €228.01 Million
≈ $266.57 Million
€34.21 Million
≈ $39.99 Million
0.150x +5.70%
2011-12-31 €211.29 Million
≈ $247.02 Million
€29.99 Million
≈ $35.06 Million
0.142x -23.87%
2010-12-31 €184.27 Million
≈ $215.43 Million
€34.36 Million
≈ $40.17 Million
0.186x -27.85%
2009-12-31 €154.95 Million
≈ $181.15 Million
€40.05 Million
≈ $46.82 Million
0.258x +61.72%
2008-12-31 €137.05 Million
≈ $160.23 Million
€21.90 Million
≈ $25.61 Million
0.160x -45.09%
2007-12-31 €127.87 Million
≈ $149.49 Million
€37.22 Million
≈ $43.51 Million
0.291x +38.50%
2006-12-31 €111.15 Million
≈ $129.94 Million
€23.36 Million
≈ $27.31 Million
0.210x -39.22%
2005-12-31 €86.82 Million
≈ $101.50 Million
€30.01 Million
≈ $35.09 Million
0.346x +19.09%
2004-12-31 €71.38 Million
≈ $83.45 Million
€20.72 Million
≈ $24.23 Million
0.290x --

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic
Market Cap
$987.70 Million
€844.84 Million EUR
Market Cap Rank
#9076 Global
#146 in France
Share Price
€71.60
Change (1 day)
+1.13%
52-Week Range
€67.20 - €91.00
All Time High
€149.34
About

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more